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Abstract
Background: Mouse mammary tumor virus (MMTV) encodes the Rem protein, an HIV Rev-like
protein that enhances nuclear export of unspliced viral RNA in rodent cells. We have shown that
Rem is expressed from a doubly spliced RNA, typical of complex retroviruses. Several recent
reports indicate that MMTV can infect human cells, suggesting that MMTV might interact with
human retroviruses, such as human immunodeficiency virus (HIV), human T-cell leukemia virus
(HTLV), and human endogenous retrovirus type K (HERV-K). In this report, we test whether the
export/regulatory proteins of human complex retroviruses will increase expression from vectors
containing the Rem-responsive element (RmRE).
Results: MMTV Rem, HIV Rev, and HTLV Rex proteins, but not HERV-K Rec, enhanced
expression from an MMTV-based reporter plasmid in human T cells, and this activity was
dependent on the RmRE. No RmRE-dependent reporter gene expression was detectable using Rev,
Rex, or Rec in HC11 mouse mammary cells. Cell fractionation and RNA quantitation experiments
suggested that the regulatory proteins did not affect RNA stability or nuclear export in the MMTV
reporter system. Rem had no demonstrable activity on export elements from HIV, HTLV, or
HERV-K. Similar to the Rem-specific activity in rodent cells, the RmRE-dependent functions of
Rem, Rev, or Rex in human cells were inhibited by a dominant-negative truncated nucleoporin that
acts in the Crm1 pathway of RNA and protein export.
Conclusion: These data argue that many retroviral regulatory proteins recognize similar complex
RNA structures, which may depend on the presence of cell-type specific proteins. Retroviral
protein activity on the RmRE appears to affect a post-export function of the reporter RNA. Our
results provide additional evidence that MMTV is a complex retrovirus with the potential for viral
interactions in human cells.
Background
Mouse mammary tumor virus (MMTV) is a betaretro-
virus that encodes three accessory and regulatory
proteins, a superantigen (Sag) [1-3], a dUTPase [4] and
an RNA export protein, Rem [5]. Rem is a 33 kDa protein
that is encoded by a doubly spliced mRNA [5, 6]. The
N-terminal portion of Rem contains nuclear and
nucleolar localization signals as well as an arginine-rich
motif similar to the RNA export proteins, Rev, Rex, and
Rec, produced by the complex retroviruses, human
immunodeficiency virus (HIV), human T-cell leukemia
virus (HTLV), and human endogenous retrovirus type-K
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(HERV-K), respectively [5, 6]. Our previous data have
shown that Rem is larger than other retroviral export
proteins due to a unique C-terminus, which negatively
regulates Rem-mediated RNA export activity [5]. Nega-
tive regulation of MMTV transcription also occurs during
viral replication in several cell types [7-10]. MMTV has a
complex life cycle that allows transmission through
maternal milk to susceptible offspring using dendritic
cells as well as B and T cells [11]. Amplification of MMTV
in various lymphoid cell types requires virally encoded
Sag to effectively transfer virus from lymphocytes to
mammary epithelial cells during puberty [12, 13]. Both
the sophisticated mode of transmission and production
of multiple accessory and regulatory proteins imply that
MMTV is a complex retrovirus [5].
MMTV may interact with human complex retroviruses.
Multiple laboratories previously have reported that
MMTV sequences are detectable in human breast cancer
or lymphomas, but not most normal tissues, using PCR
to amplify one or more regions of the viral genome
[14-18]. However, not all studies agree [19, 20]. Recent
data indicate that MMTV can infect and integrate into
chromosomal DNA of cultured human cells [21, 22],
suggesting that zoonotic infections can occur. Further-
more, MMTV is highly related to HERV-Ks [also known
as human MMTV-like proviruses (HMLs)] [23]. Some
intact HERV-K/HML-2 proviruses have been described,
consistent with their relatively recent acquisition in the
human genome, yet none of these proviruses are known
to be infectious [24-26]. A number of HERV-Ks are
highly expressed in specific tissues [23, 27]. In addition,
a recent report indicates that antibodies to HERV-K/
HML-2 are detectable in the plasma of breast cancer and
lymphoma patients, and these titers dropped when the
cancers were treated. HERV-K reverse transcriptase
activity, viral RNA, processed viral proteins, and virus-
like particles also could be detected in patient plasma
[28]. Together, these experiments suggest that sporadic
MMTV infections of human cells may result in interac-
tions with HERV-Ks or the generation of recombinant
infectious viruses.
Prior experiments indicate that HIV Rev and HTLV Rex
can activate expression from reporter plasmids contain-
ing the HERV-K Rec-responsive element (RcRE) [29].
Because of sequence and organizational similarities
between MMTV and HERV-K and the potential for
MMTV infection of human cells, we have tested for
interactions between heterologous retroviral export
proteins and the Rem-responsive element (RmRE)
using our previously described reporter vector, pHMRluc
[5]. Surprisingly, Rev and Rex, but not Rec, could activate
MMTV-based reporter gene expression in human T cells
and was dependent on the presence of the RmRE. Cell
fractionation experiments followed by RNA quantitation
suggested that each of the regulatory proteins, including
Rem, did not affect RNA export or stability using an
MMTV-based reporter vector. Rem activity was undetect-
able using heterologous response elements. These results
suggest that retroviral export elements recognize similar
features of RNA structure and support the idea that
MMTV is a complex murine retrovirus that may interact
with other retroviruses in human cells.
Results
To determine if the RNA export proteins from known
complex retroviruses function on the MMTV RmRE, we
used the reporter vector, pHMRluc (Figure 1) [5]. This
vector contains the cytomegalovirus (CMV) promoter
upstream of the 3' end of the MMTV genome as well as
the Renilla luciferase gene between splice donor and
acceptor sites [5]. The RmRE appears to span the
envelope-3' LTR junction [5, 30]. Detection of luciferase
activity in transfected cells indicates cytoplasmic export
of unspliced transcripts since splicing would remove the
reporter gene. Rem expression gave a 25 to 30-fold
increase in luciferase expression in Jurkat human T cells
relative to cells co-transfected with the reporter plasmid
and empty vector (pEGFP), whereas no increase was
observed using the reporter lacking a functional RmRE
(Figure 2A). Interestingly, Rev expression in Jurkat cells
also increased luciferase activity approximately 3-fold
compared to control cells expressing only the reporter
plasmid (Figure 2A). This result is statistically significant
and has been repeated in multiple experiments. Further,
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Figure 1
Structure of plasmids used to determine RNA export
activity. The CMV promoter (gray box) is shown inserted
upstream of the 3' end of the MMTV provirus (solid
horizontal line). The 3' MMTV LTR is shown by a white box.
The Renilla luciferase gene (black box) is located between the
splice donor (SD) and acceptor (SA) sites. The smaller
hatched box indicates the SV40 polyadenylation region. The
smaller gray box shows the position for insertion of
response elements for other retroviral export proteins
within the HMΔeLTRluc plasmid.
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Rev-mediated enhancement of reporter activity required
the RmRE since deletion of this element eliminated the
effect (compare results using pHMRluc or pHMΔeLTRluc
reporter plasmids) (Figure 2A). The Rev effect on
reporter gene expression in Jurkat cells, which is
abolished by the Δ3 mutation in the leucine-rich nuclear
export sequence (data not shown) [31], is believed to
interact with the cellular export protein Crm1 [32, 33].
In addition, Rev and Rem-mediated induction of
pHMRluc activity was tested by transient transfections
of 293T human kidney cells (Figure 2B). Although Rem
gave a small, but statistically significant, increase in
reporter activity, Rev did not. Both Rem and Rev were
expressed as GFP-fusions to allow comparison of the
relative expression of these regulatory proteins, and
similar amounts were detected using a GFP-specific
antibody and Western blotting after transfection of
both cell types compared to the actin loading control
(Figure 2C and data not shown).
The effect of Rev on the MMTV-based luciferase vector
also was determined in HC11 mouse mammary cells
since breast epithelial cells are permissive for MMTV
replication [34]. Rem gave a 4 to 5-fold increase in HC11
cells and was dependent on the presence of the RmRE
(Figure 3A), whereas Rev gave no detectable effect in the
presence or absence of the response element. Western
blots verified protein expression (Figure 3B). Therefore,
the heterologous export protein, Rev, appears to function
in a cell-type and/or species-specific manner on the
MMTV RmRE.
Transfection experiments also were performed after
expression of HTLV Rex in the presence of pHMRluc
(Figure 4). Rex1 and Rex2 from HTLV-1 and -2,
respectively, stimulated luciferase activity in Jurkat cells
in a RmRE-dependent manner, although the magnitude
of the effect (ca. 5 to 7-fold) was greater than that
observed for Rev (Figure 4A). Rex also was tested for
stimulation of reporter gene expression in human kidney
epithelial cells (293T) [35]. Rem and Rex stimulated
reporter expression 2-fold and 4-fold, respectively, and
was dependent on the RmRE (Figure 4B). Western
blotting showed similar expression of these proteins
(Figure 4C and data not shown). Thus, the stimulation
was dependent on the presence of the RmRE in human
cells.
No RmRE-dependent effect of Rex1 or 2 was observed in
mouse HC11 epithelial cells (Figure 5A), although Rex
has been shown to function in mouse fibroblast cells
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Figure 2
Activity of HIV-1 Rev on the MMTV RmRE in human
cells. A. Reporter activity of RevGFP on the RmRE in Jurkat
T cells. Cells were electroporated with pHMRluc or
pHMΔeLTRluc (1 μg) with either 20 μg of EGFP, RemGFP or
RevGFP expression plasmids. Cytoplasmic extracts were
prepared and analyzed for Renilla luciferase (Rluc) activity.
Average luciferase values for each reporter plasmid in the
absence of Rev or Rem have been assigned a value of 1, and
the other samples are reported relative to this value after
normalization for DNA uptake using a co-transfected pGL3
reporter plasmid expressing firefly luciferase. Standard
deviations from the average of triplicate transfections are
indicated. B. Reporter activity of RevGFP on the RmRE in
293T cells. Cells were transfected using calcium phosphate
precipitation of DNA as described in the Methods section.
Values are reported as described in panel A. C. Western
blotting confirms similar expression of Rev and Rem. A
Western blot of protein extracts from Jurkat cells is shown.
The unfused GFP band is not visible in this portion of the gel.
The upper panel shows reactivity with GFP-specific antibody;
the lower panel shows equal loading of protein extracts using
an actin-specific antibody. Size markers are given in
kilodaltons.
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[36]. However, 2- to 4-fold increases were observed using
both the pHMRluc and pHMΔeLTRluc vectors, which we
attribute to cell-type-specific effects of Rex since greatly
diminished activity was observed in human cells after
RmRE deletion (Figure 4A). Furthermore, vectors that
substituted the RmRE with the RxRE gave a 7- to 9-fold
increase in luciferase expression in HC11 cells, which
was dependent on Rex, but not Rem (see Figure 8).
Expression of GFP-fusion proteins was equivalent in
mouse and human cells as determined by Western
blotting (Figures 4C and 5B). Therefore, mouse epithe-
lial cells may lack cell-type specific proteins that allow
Rex function on the MMTV RmRE. Like Rev, these results
suggest that the enhancement of reporter activity by Rex
is species or cell-type specific, whereas the effect of Rem
is not.
Although HIV and HTLV are only distantly related to
MMTV, the human endogenous retrovirus type K (HERV-
K) has sequence similarity to MMTV and is a betaretrovirus
that encodes the RNA export protein, Rec [37]. Both HERV-
K Rec and MMTV Rem are translated from the same open
reading frame as their respective envelope signal peptides,
but Rec lacks the extensive autoregulatory region found in
the Rem C-terminus [5, 29]. Rec expression in either Jurkat
(Figure 6A) or HC11 (Figure 6C) cells failed to enhance the
basal luciferase activity of pHMRluc despite demonstrable
expression of the GFP-fusion proteins (Figure 6B and data
not shown). Together, these results indicated that Rev and
Rex, but not Rec, could stimulate expression of unspliced
RNA containing the RmRE.
To determine whether the HIV Rev and HTLV Rex proteins
enhanced luciferase expression from the MMTV-based
reporter vector through increases in RNA export or another
mechanism, transfected Jurkat cells were subjected to
cellular fractionation. After different detergent concentra-
tions were tested to optimize the integrity of the fractions,
nuclear and cytoplasmic RNAs were obtained, and samples
were subjected to Northern blotting and staining to
confirm the isolation of intact RNA and absence of rRNA
precursors in the cytoplasmic fractions (Figure 7A).
Subsequently, Jurkat cells were subjected to electroporation
with the HIV-based reporter vector, pDM128, in the
presence and absence of a RevGFP expression plasmid.
Rluc luc
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Figure 3
HIV-1 Rev activity on the MMTV RmRE in mouse
mammary cells. A. Reporter activity in HC11 mouse
mammary cells. Values are reported as described in Figure 2.
B. Western blot of Rem and Rev expression in HC11 cells.
Similar expression of the GFP-fusion proteins was observed
as determined using antibodies specific for GFP (upper panel)
or actin (lower panel). Size markers are given in kilodaltons.
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Figure 4
Activity of HTLV Rex1 and Rex2 on MMTV RmRE-
containing reporter plasmids in human cells.
A. Reporter activity in Jurkat T cells. B. Reporter activity in
293T cells. Values are reported as in Figure 2, except that
Rex1GFP or Rex2GFP expression plasmids were used.
C. Western blotting confirms similar expression of Rem and
Rex. Samples from Jurkat transfections are shown and
analyzed with antibodies specific for GFP (upper panel) or
actin (lower panel). Size markers are given in kilodaltons.
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Transfected cells were used to obtain nuclear and
cytoplasmic fractions. RNA samples from these fractions
then were subjected to semi-quantitative reverse transcrip-
tion (RT)-PCRs using primers specific for the cat reporter
gene (Figure 7B). As expected [38-40], increased cytoplas-
mic levels of unspliced RNA containing the chloramphe-
nicol acetyl transferase (cat) gene in pDM128 are observed
in the presence of Rev (compare lanes 6 and 8 as well as
10 and 12 with two different amounts of cDNA). Although
controls indicated that the nuclear fractions in this
experiment were contaminated with DNA (Figure 7B,
lanes 1 and 3), the absence of contaminating DNA in the
cytoplasmic fractions further substantiated the integrity of
the cellular fractionations. RT-PCRs using gapdh-specific
primers confirmed similar levels of intact RNA (lanes
13–20). PCR conditions did not appear to be saturated
since higher product levels could be observed for the more
abundant gapdh mRNA than for reporter transcripts.
Additional experiments then were performed in Jurkat
cells using the MMTV-based reporter vector (pHMRluc)
and co-transfected expression vectors for GFP-tagged
Rem, Rev, or Rex. RNAs from cytoplasmic and nuclear
fractions were treated with DNase I and subjected to
semi-quantitative RT-PCRs using primers specific for the
Renilla luciferase gene or gapdh [5] (Figure 7C). PCRs
without added reverse transcriptase showed that DNA
contamination was absent (data not shown). Cytoplas-
mic RNA levels then were quantitated using ImageJ
software after normalization for gapdh expression.
Unexpectedly, these experiments indicated that Rem,
Rev, or Rex had little effect on the levels of RNA in the
nucleus or cytoplasm in Jurkat cells, suggesting that these
proteins do not affect intron-containing transcript
stability or export (Figure 7D).
We also tested the ability of Rem to affect expression
using heterologous response elements in both Jurkat and
HC11 cells (Figure 8). The response elements from
HERV-K, HTLV-1, HTLV-2, and HIV were cloned into
pHMΔeLTRluc, which lacks a functional RmRE, resulting
in the reporter plasmids pRcRERluc, pRxRE1Rluc,
pRxRE2Rluc, and pRRERluc, respectively (Figure 1). As
expected, each of these plasmids gave significantly
Rluc luc
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Figure 5
HTLV Rex1 and 2 activity on the MMTV RmRE in
mouse mammary cells. A. Reporter activity in HC11
mouse mammary cells. Values are reported as in Figure 2,
except that Rex1GFP and Rex2GFP expression plasmids
were used. B. Western blots of extracts from Rex and Rem-
transfected HC11 cells. A GFP-related band is observed in
this blot (asterisk; lanes 1 and 5), but the major band is not
visible in this portion of the gel (upper panel). Similar levels
of Rem, Rex1 and Rex2 fusion proteins are observed using
the GFP-specific antibody. Incubation with an actin-specific
antibody revealed similar protein loading in each lane (lower
panel). Size markers are given in kilodaltons.
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Figure 6
Activity of HERV-K Rec on a reporter plasmid
containing the MMTV RmRE in human and mouse
cells. A. Reporter activity in Jurkat T cells. B. Western
blotting of Rem and Rec expression in Jurkat cells. Results
using antibodies specific for GFP (upper panel) and actin
(lower panel) are shown. Size markers are given in
kilodaltons. C. Reporter activity in HC11 mouse mammary
cells. Values in panels A and C are reported as in Figure 2,
except that a RecGFP expression plasmid was used.
Retrovirology 2009, 6:10 http://www.retrovirology.com/content/6/1/10
Page 5 of 13
(page number not for citation purposes)
Rluc Rluce luc e luc
gapdhcat
RlucRluc luclucRluc lucRluc luc
Rluc
gapdh
R
lu
c
R
lu
c
Rluc luc Rluc luc
Figure 7
Fractionation experiments indicate that Rev and Rex have little effect on export or stability of unspliced
RmRE-containing reporter transcripts. A. Integrity of cytoplasmic and nuclear fractions obtained from transfected Jurkat cells.
Jurkat cells were subjected to transfection by electroporation and, after 48 hr, cells were fractionated. Fractions were used for RNA
extraction and subjected to Northern blotting prior to staining with methylene blue and photography. The nuclear ribosomal
precursors (arrows on the left) and cytoplasmic mature ribosomal RNAs (arrows on the right) are indicated. B. Semi-quantitative RT-
PCRs of fractionated RNA obtained from Jurkat cells transfected with the HIV-based reporter vector pDM128. Cells were co-
transfected with pDM128 and either pEGFPN3 control vector (no Rev) or RevGFP (Rev) expression plasmids as indicated by minus or
plus signs. After 48 hr, cells were fractionated, and RNA samples were extracted and subjected to RT-PCRs using primers for the cat
gene or glyceraldehyde-3-phosphate dehydrogenase (gapdh). Fractions (FR) used for RNA extraction are indicated as nuclear (N) or
cytoplasmic (C). PCRs performed in the absence of reverse transcriptase (RT) are indicated (lanes 1–4) (equivalent to 2 μl of a diluted
cDNA reaction). Either 2 μl (lanes 5–8 and 13–16) or 4 μl (lanes 9–12 and 17–20) of the diluted cDNAs were used for RT-PCRs as
indicated in Methods to show that the reactions were performed in the linear range. Samples were analyzed on a 1.5% agarose gel using
either 5 (gapdh) or 15 μl (cat) of the 50 μl reaction. Markers (M) are given in basepairs (bp).C. Semi-quantitative RT-PCR assays of the
MMTV-based reporter plasmids in the presence or absence of RemGFP, RevGFP, and RexGFP. Semi-quantitative RT-PCRs were
performed using RNA extracted from transfected Jurkat cells and primers specific for the Renilla luciferase (Rluc) or gapdh genes. Left
and right panels show results of two different transfection experiments. M =DNAmarkers (in bp); P =HMRluc plasmid positive control;
H20 = PCR without added cDNA.D. Quantitation of RT-PCR results from cytoplasmic fractions of cells transfected with the MMTV-
based reporter plasmid. Stained RT-PCR products from panel C were quantitated using ImageJ software and normalized for RNA
amounts and integrity using gapdh expression. The normalized RNA levels obtained from each reporter plasmid (in the presence of the
control EGFP expression vector only) were assigned values of 1, and the other samples have been reported relative to these values.
These results are representative of at least three different transfection experiments.
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increased (100 to 1300-fold) luciferase activity in human
Jurkat T cells in the presence of their homologous export
protein compared to the activity of the reporter plasmid
in the presence of unfused GFP (Figure 8A). Similar
transfections also were performed in HC11 mouse
mammary cells (Figure 8B). Since Rev had no demon-
strable activity on the RmRE in HC11 cells, Rev and the
pRRERluc construct were not tested in these cells. Rec,
Rex1, and Rex2 showed increased reporter activity with
their homologous response elements in HC11 mammary
cells, but function was substantially reduced compared
to that observed in Jurkat cells (Figure 8A). Further, Rem
failed to enhance expression from any of the tested
response elements in either cell line. Western blotting
with GFP-specific antibody confirmed similar levels of
each export protein (data not shown). These results
suggest that the RmRE secondary and/or tertiary struc-
ture does not duplicate other retroviral export elements.
However, the ability of Rem, Rev and Rex to function on
the RmRE in human cells suggests common features of
RNA recognition.
We have previously shown that Crm1 is required for
Rem function in HC11 mouse mammary cells [5]. Rev
and Rex also use Crm1 for the export of intron-
containing homologous RNAs [32, 41]. To test the
involvement of Crm1 in human cells, we tested whether
a dominant-negative nucleoporin involved in the Crm1
export pathway (ΔCAN) [42] would affect the increased
luciferase activity mediated by Rem, Rev, or Rex in Jurkat
T cells. The dominant-negative protein gave a statistically
significant suppression of Rem, Rev, Rex1 and Rex2
activation of the HMRluc vector, although the greatest
effect was observed with Rem (Figure 9). Suppression by
the ΔCAN mutant did not appear to be toxic for the cells
under these conditions (data not shown). Furthermore,
our previous data indicated that overexpression of a
dominant-negative Tap/NXF1 mutant (TapA17) had no
effect on Rem-induced reporter activity in HC11 mouse
cells [5]. Similarly, TapA17 overexpression in human
Jurkat cells did not affect Rev, Rex, or Rem-mediated
stimulation of HMRluc activity (not shown). Neither
ΔCAN nor TapA17 had a dramatic effect on reporter
activity in the absence of a regulatory protein (not
shown). Together with previous results, these data
suggest that enhancement of reporter activity by Rem
requires Crm1 and that the regulatory proteins facilitate
a post-export function that depends on the RmRE.
Discussion
Our previous experiments have shown that MMTV Rem
functions in nuclear export of unspliced viral RNA in
rodent cells [5]. In this manuscript, we have shown that
Rem functions in human cell lines. Our results also
indicate that Rev and Rex can increase reporter gene
expression by interaction with the MMTV RmRE in
human Jurkat T cells (Figures 2 and 4). Rex also could
Figure 9
Rev and Rex use the Crm1 pathway to enhance
expression of RmRE-containing RNAs. Jurkat cells were
electroporated with 1 μg of pHMRluc and 1 μg of pGL3
control firefly luciferase plasmid. The EGFP, RemGFP,
RevGFP, Rex1GFP or Rex2GFP expression plasmids (10 μg)
were added as indicated with or without 20 μg of the plasmid
expressing the dominant-negative nucleoporin (pcΔCAN)
[42]. All samples were adjusted to the same concentration of
DNA with empty vector (pBC12/CMV) prior to transfection.
Luciferase activity was determined as described in Figure 2.
Renilla luciferase values were normalized for DNA uptake
using firefly luciferase activity, and the pHMRluc sample
cotransfected with EGFP was assigned a relative value of 1.
Figure 8
Rem lacks activity on heterologous RNA export
elements. A. Rem activity on heterologous export
elements in Jurkat T cells. Cells were transfected with
reporter plasmids containing the indicated response
elements described in Figure 1 with or without expression
vectors for retroviral export proteins. B. Rem activity on
heterologous export elements in HC11 mouse mammary
cells. Relative luciferase values in both panels are reported as
described in Figure 2.
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function on the RmRE in 293T HEK cells. Prior data
indicate that some retroviral export proteins function on
heterologous retroviral RNAs. For example, Rex can bind
and function on both the RRE and the RxRE [43, 44].
However, the interaction is not reciprocal since Rev
cannot act on the RxRE [43]. In this respect, the RmRE is
quite permissive since it is required for enhancement of
luciferase activity by Rem, Rev and Rex in human T cells.
No effect of Rem was observed on the HIV and HTLV
response elements (Figure 8). Surprisingly, the Rec
export protein from the human retrovirus most closely
related to MMTV, HERV-K/HML, had no effect on
expression from the MMTV RmRE (Figure 6). Further,
no effect of Rem was observed on the RcRE, although
both HIV Rev and HTLV Rex have been reported to
increase expression from the HERV-K response element
[29]. However, polymorphisms have been observed in
different HERV-K proviruses [29], and it is possible that
other RcRE variants might function with MMTV Rem or
that other Rec variants may be functional on the RmRE.
Given that the regulatory proteins require formation of
specific secondary structures rather than a simple
primary sequence [29, 45-48], Rec also may need
secondary or tertiary structures not found in the RmRE.
The effect of Rev and Rex on the MMTV RmRE appears to
be specific in human cells by several criteria. First,
increases in reporter gene activity that were dependent
on the RmRE were only observed in human cells with
Rex or Rev. Although different results have been reported
[36, 49], Rev appears to function in both mouse and
human cell lines using vectors with a design similar to
that of pHMRluc, but based on the 3' end of the HIV
genome [50]. Rex also has been reported to function in
both human and mouse cells [36], although Rev and Rex
have primarily been tested in fibroblasts [36, 50], which
are not natural target cells for HIV, HTLV or MMTV.
Second, a Rev mutant defective in the nuclear export
sequence gave no specific effect in the pHMRluc assay,
similar to the effect observed with RRE-containing
vectors [31]. Third, a dominant-negative mutant nucleo-
porin in the Crm1 pathway inhibited Rem, Rev, and Rex
activation of reporter expression through the RmRE in
human cells. Rem previously has been shown to require
Crm1 in rodent cells [5], whereas Rev and Rex use Crm1
in human cells [33, 41]. Fourth, no effect of Rec was
observed on the RmRE in either mouse or human cells.
Fifth, insertion of different response elements in the
pHMRluc vector yielded the expected increases in
luciferase activity after expression of the homologous
export protein. These results indicate that the MMTV-
based vector allows the activity of other response
elements and that each of the GFP-fusion proteins is
functional (Figure 8). Although we may have lowered
the sensitivity for detection of regulatory protein
function in mouse cells by testing fusion proteins,
Western blotting using an antibody that recognizes all
of the fusion proteins allowed us to verify that similar
amounts of each protein were expressed in transfection
assays. Prior experiments by Dangerfield et al. suggest
that Rev can bind to the MMTV LTR and stimulate
luciferase expression from constructs containing the
MMTV LTR in monkey cells [51]. Our studies differ
significantly since their data were obtained by insertion
of MMTV sequences into an HIV-based vector, and the
ability of Rem to function on heterologous response
elements was not determined. Furthermore, only the
MMTV LTR, which lacks a portion of the RmRE [30] (our
unpublished data), was present in the HIV vector [51].
Thus, our data argue for a specific effect of HIV and HTLV
regulatory proteins on the MMTV RmRE in human cells.
Previous experiments from our laboratory have shown
that human Jurkat T cells can produce mature MMTV
particles after transfection of a cloned provirus, and these
particles are infectious for mice [52, 53]. Consistent with
this observation, our current data indicate that Rem can
function in human cells. The reports of MMTV infection
of human cells and detection of MMTV sequences in
breast cancers and lymphomas [14-18] appear to be
feasible since most steps of viral replication occur in
human cells. Cell entry would provide the primary
barrier to infection [54]. Although human cell infections
appear to be inefficient and infrequent, certain cell types
may have an additional entry receptor, which is
dependent on cellular activation or differentiation
state. The ability of Rev and Rex to function on the
MMTV RmRE in human T cells suggests that rare
interactions of these viruses could occur.
Rev is known to have multiple functions, including
enhancement of RNA encapsidation of HIV and SIV-
based vectors [55]. Our previous results indicated that
export of unspliced MMTV RNA and Gag expression
from a transfected MMTV provirus requires Rem in rat
fibroblast cells [5]; encapsidation was not measured. The
reporter vector pHMRluc is based on the 3' end of the
MMTV provirus and has been shown to be responsive to
Rem only in the presence of the RmRE in rat, mouse, and
human cells [5] (this study). Further, the use of the
Renilla luciferase gene in the vector provides both a
sensitive and highly quantitative assay, which is difficult
to achieve using RNA fractionation experiments and
Northern blotting. Rev/RRE interactions also have been
shown to affect Gag trafficking and HIV assembly, and it
has been suggested that export elements facilitate
"marking" of RNAs in the nucleus for particular events
in the cytosol [56]. Our experiments show that Rev and
Rex function through Crm1 on pHMRluc (Figure 9).
Nevertheless, cell fractionation experiments with the
Retrovirology 2009, 6:10 http://www.retrovirology.com/content/6/1/10
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pHMRluc vector indicate that the regulatory proteins
primarily lacked effects on nuclear RNA export and RNA
stability (Figure 7). Since effects on cytosolic RNA levels
and Gag production were clearly demonstrable using an
MMTV proviral clone with a transposon insertion into
the rem coding sequence [5], our results with the
pHMRluc vector suggest that different sequence elements
at the 5' end of the full-length MMTV RNA allow
additional effects of Rem on RNA stability and/or export.
Published experiments indicate a wide variability (0 to
10-fold) in Rev function on RNA export [55, 57-60].
Suboptimal splicing appears necessary to allow the
accumulation of genomic HIV RNA and the export
effects of Rev [61]. Efficiency of splicing of full-length
MMTV RNA versus pHMRluc vector RNA appears to be
an unlikely explanation for differences in observed
nuclear export. The splice donor and acceptor sites
found in pHMRluc are those normally used to generate
either the rem or sag fully spliced mRNAs, and the low
abundance of these RNAs in MMTV-infected cells [6, 62]
suggests that splicing at these sites is suboptimal
compared to those used to produce MMTV env RNAs
from genomic RNAs. Rev also appears to overcome
effects of several cis-acting repressive sequences, includ-
ing sequences within gag-pol [63, 64] as well as env
sequences that overlap with the RRE [65, 66]. The
repressive sequences in HIV gag-pol appear to be AU-rich,
and mutation led to increased steady state RNA
levels [64]. The pHMRluc vector lacks gag-pol sequences
(Figure 1), but our previous work with Rem-deficient
MMTV genomic clones was consistent with defective
RNA export, rather than a stabilization effect.
The cell fractionation data with pHMRluc (Figure 7) and
MMTV genomic length RNA [5] argue that Rem has
multiple functions, including both export and post-
export activities. Rev and Rex have been reported to
function at the level of translation [59, 67, 68]. Specific
cis-acting elements found in the RU5 and gag regions of
several retroviruses appear to affect translation [69-73],
but such sequences are absent in the pHMRluc vector.
Since the post-export function of Rem with pHMRluc is
sensitive to competition with a Crm1-binding site on
Nup214 (ΔCAN) (Figure 9), it is possible Crm1 dictates
Rem protein export independent of the vector RNA.
Nevertheless, Rem binding to the 3' RmRE, perhaps in
the cytoplasm or after binding of a cellular protein in the
cytoplasm, may promote a post-export step, such as
translation. Rem binding through sequence elements at
the 5' end of the MMTV RNA may increase Crm1-
dependent export, but such 5' elements may not be
necessary for detection of the post-export activity of
the pHMRluc vector. Our current data indicate that the
RmRE maps to the junction of the envelope gene and the
3' LTR using deletion analysis with the pHMRluc vector
and co-transfection of a Rem expression vector (see
below). Interestingly, these results suggest that all MMTV
mRNAs contain the 3' RmRE, unlike the RRE, which
would be removed from completely spliced HIV mRNAs,
such as those encoding Tat, Nef, and Rev [74]. Previously
published data indicate that export of unspliced genomic
MMTV RNA, but not partially spliced envelope RNA, is
leptomycin B and, by implication, Crm1-dependent [6].
Such experiments suggest that only unspliced MMTV
RNA is selectively exported. Therefore, it is possible that
the MMTV genome contains two RmREs, one at the 5'
end of viral RNA present only in unspliced RNA and a
second element at the 3' end present in all MMTV RNAs.
The 3' element may facilitate translation of all mRNAs,
whereas the 5' element would specifically facilitate
nuclear export of genomic RNA. Cell-type specific effects
also may occur. Characterization of the molecular
mechanisms of Rem function will require further
investigation.
Both the pHMRluc vector and MMTV genomic RNAs
contain a RmRE that spans the envelope-LTR junction
[30] (Mertz et al., in preparation). Published data
indicate that retroviral export/regulatory proteins bind
to complex RNA structures that have multiple stems and
loops [29, 48, 75, 76]. Rev and Rec appear to bind to
RNA stems with a bulge, and recognition of heterologous
elements may not occur through the same primary
sequence as the homologous protein [29]. Our current
data using RmRE susceptibility to several RNases is
consistent with a complex structure containing multiple
stems and bulges, which encompasses a region of ca. 500
bases (Mertz et al., in preparation) rather than the single
stem with multiple bulges previously proposed [30]. The
export of unspliced retroviral RNA is known to require
specific cellular proteins, such as hnRNPs and Sam68
[77, 78], and binding of these cellular proteins may
determine the cell-type specificity observed in our
experiments. Since retroviral export/regulatory proteins
recognize certain RNA secondary structures [48, 79], one
or more of these proteins may bind to and function on
specific cellular RNAs as reported for Rex [80].
RNA-binding proteins appear to regulate several steps
following transcription, leading to coordinated regula-
tion of cellular RNAs with related functions called RNA
regulons [81]. MMTV replication in the mouse requires
several different cell types, including lymphocytes and
mammary epithelial cells [34]. We previously have
shown that MMTV replication is controlled at the
transcriptional level during mammary gland develop-
ment coordinately with several milk-specific genes [82,
83]. Therefore, post-transcriptional control of MMTV
expression also may be modulated by Rem depending
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on the cell type and state of differentiation. Our results
provide additional evidence that MMTV is a murine
complex retrovirus with the potential to interact with
human retroviruses [5].
Methods
Cell lines and transfections
Jurkat human T lymphoma cells were maintained in RPMI
media supplemented with 5% fetal calf serum (FCS),
gentamicin sulfate (50 μg/ml), penicillin (100 U/ml) and
streptomycin (50 μg/ml). HC11 normal murine mammary
epithelial cells were maintained in RPMI supplemented
with 10% FCS, gentamicin sulfate (50 μg/ml), penicillin
(100 U/ml), streptomycin (50 μg/ml), insulin (0.5 μg/ml)
and epidermal growth factor (0.5 μg/ml). The 293T human
embryonic kidney cells were grown as previously described
[84] in Dulbecco's modified Eagle's medium containing
7.5% fetal bovine serum and antibiotics.
Jurkat cells were transfected by electroporation using a
BTX ECM600 instrument. Cells (1 × 107) were mixed
with the appropriate plasmid DNA in a volume of 400 μl
RPMI medium prior to electroporation in 4 mm gap
cuvettes (260 V, 1050 μF and 720 ohms). Transfected
cells then were incubated at 37°C in complete medium
and harvested two days after transfection for Western
blotting and reporter assays. HC11 cells also were
transfected by electroporation using a BTX electropora-
tor. Cells (1 × 107) were mixed with the appropriate
plasmid DNA in a volume of 200 μl of RPMI prior to
electroporation in 2 mm gap cuvettes at 140 V, 1750 μF,
and 72 ohms. The 293T cells were transfected essentially
as described [35] by the calcium phosphate method. On
the day before transfection, 5 × 105 cells were added to
each well of a 6-well plate, and DNA (total of 6 μg) in
0.25 M CaCl2 (100 μl) was added dropwise to 100 μl of
2× HBS (280 mM NaCl, 10 mM KCl, 1.5 mM disodium
phosphate, 12 mM dextrose and 50 mM HEPES, pH
7.05) with vortexing. The precipitate was allowed to
form at room temperature for 10 to 15 minutes, and the
solution was added dropwise to the cells in growth
medium. Cells then were incubated at 37°C from 4 to 8
hours, the medium was removed, and cells were washed
in phosphate-buffered saline prior to replacement with
fresh growth medium. Transfected cells were harvested
after two days and assayed for reporter gene levels and
protein expression. All transfections were performed in
triplicate and contained the same total amounts of
plasmid DNA. A constant amount of pGL3 control
containing the firefly luciferase gene was included in
each transfection to normalize for any differences in
DNA uptake. Some experiments also tested for DNA
uptake after determination of the percentage of cells
expressing a GFP control vector using FACS analysis. No
significant differences were observed using either of the
two methods. All reported experiments were repeated at
least twice with similar results.
Plasmid constructs
The RemGFP, HMRluc and HMΔeLTRluc plasmids have
been described [5]. The plasmid EGFPN3 was obtained
from Clontech, and pGL3-Control plasmid was obtained
from Promega. The expression plasmid for the Δ3
mutation in the Rev nuclear export sequence was received
from Dr. Tom Hope. The pcΔCAN (dominant-negative
Nup214) and pcTapA17 (dominant-negative Tap/NXF1)
expression plasmids were kindly provided by Dr. Bryan
Cullen (Duke University). The empty vector pBC12/CMV
was obtained by excision of the ΔCAN cDNA from
pcΔCAN. The pRRERluc plasmid was constructed by
insertion of the HIV-1 RRE, amplified from the
pDM128 vector (provided by Dr. Tom Hope), into an
engineered ScaI site downstream of the splice acceptor site
and upstream of the SV40 poly(A) signal in HMΔeLTRluc.
The plasmids RxRE1Rluc and RxRE2Rluc were generated
by amplification of RxRE1 and RxRE2 from pcgagRxREI
and pcgagRxRE2, respectively (provided byDr. Pat Green)
and insertion into an engineered ScaI site downstream of
the splice acceptor site and upstream of the SV40 poly(A)
signal in pHMΔeLTRluc. The RcRERluc plasmid was made
by amplification of the RcRE from pJY76 (provided by Dr.
Bryan Cullen) and insertion into an engineered ScaI site
downstream of the splice acceptor site and upstream of
the SV40 poly(A) signal in pHMΔeLTRluc. RevGFP,
Rex1GFP, Rex2GFP and RecGFP were generated by
cloning of the individual cDNAs in-frame with a C-
terminal GFP tag in the vector EGFPN3.
Reporter assays
Luciferase assays were performed using the dual-lucifer-
ase reporter assay system (Promega) to quantitate both
Renilla and firefly luciferase activities [85].
Northern blotting and RT-PCRs
RNA was extracted from transfected Jurkat cells as
described previously [86], except that the lysis buffer
(10 mM Tris-HCl, pH 8.0, 140 mM NaCl, 1.5 mM
MgCl2, 20% glycerol) contained 0.1% NP-40 rather than
0.5% NP-40. Lysis buffer was supplemented with 10 mM
vanadyl ribonucleoside complexes (New England Bio-
labs) to inhibit ribonucleases prior to use. Cells were
mixed using a vortex mixer, examined for lysis by
microscopy, and nuclei were pelleted by centrifugation
(300 × g for 5 minutes at 4°C). The supernatant
(cytoplasmic fraction) was removed and again subjected
to centrifugation (1,200 × g for 5 minutes). The
cytoplasmic fraction was then subjected to centrifugation
at 8,000 × g for 5 minutes at 4°C. The nuclear pellet was
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washed once with lysis buffer, and the supernatant
containing residual cytoplasm discarded. Nuclear sam-
ples were processed in Tri-Reagent (2 M guanidine
isothiocyanate, 12.5 mM sodium citrate, pH 7.0, 0.25%
Sarkosyl, 0.05 M 2-mercaptoethanol, 0.2 M sodium
acetate, pH 5.2, and 50% water-saturated phenol, pH
7.5), whereas Tri-Reagent LS (Molecular Research Center,
Inc.) was used for cytoplasmic fractions. Samples then
were processed as described by the manufacturer. RNAs
were precipitated using ethanol, washed in 70% ethanol,
and precipitates were collected by centrifugation at
10,000 × g for 30 minutes at 4°C. DNA was removed
after precipitation of high-molecular-weight RNA in 3 M
sodium acetate [87], pellets were washed in 70%
ethanol, and the quantity of the RNA was determined
by absorbance readings at 260 nm. Procedures for
Northern blotting using formaldehyde-containing agar-
ose gels have been described [88]. To test for the integrity
of the cellular fractionation, each lane of the gel
contained 10 μg of fractionated RNA prior to electro-
phoresis and transfer to Hybond N+ nylon membranes
in 0.15 M sodium citrate and 1.5 M NaCl. RNA samples
then were cross-linked to the membrane using UV light
and stained with methylene blue prior to photography.
Fractionated RNAs from transfected cells also were used for
RT-PCRs. Each RNA sample (1 μg) was digested with 1 U of
DNase I (amplification grade, Invitrogen) in the presence of
0.5 μl of RNaseOUT (Invitrogen) ribonuclease inhibitor for
15 minutes at room temperature. The reaction was
terminated by the addition of EDTA to 2.5 mM and
incubation for 10 minutes at 65°C. The treated RNAs then
were incubated with 50 pmol oligo(dT)17 primer and 1mM
deoxyribonucleoside triphosphates for 5 minutes at 65°C
and then quickly cooled on ice for 5minutes. Subsequently,
first-strand buffer (Invitrogen) was added in the presence of
10 mM DTT, 20 U RNaseOUT, and 200 U of Moloney
murine leukemia virus reverse transcriptase (Invitrogen) in a
20 μl reaction. Samples were incubated for 50 minutes at
37°C and then terminated by heating at 70°C for 15
minutes. PCRs were performed using 1 μl of the cDNA
reaction, 25 pmol of each primer, 0.2mMdeoxyribonucleo-
side triphosphates, 20 mM Tris-HCl pH 8.55, 2.5 mM
MgCl2, 16mM ammonium sulfate, 100 ug/ml BSA, and 2.5
U of KlenTaq (Sigma Aldrich) in a reaction volume of 50 μl.
Samples were subjected to 3 minutes at 94°C for 3 minutes
followed by 35 cycles consisting of incubations at 94°C for
1 minute, 50°C for 45 seconds, and 72°C for 45 seconds.
The primers used to detect unspliced RNAs containing the
Renilla luciferase gene were Rluc1409(+) (5' GAT TGG GGT
GCT TGT TTG G 3') and Rluc1904(-) (5' TTC CCA TTT CAT
CAG GTG C 3'). Primers for gapdh have been described [5].
Similar reactions for cat-specific transcripts contained 5 μg
RNA and 1.5 U DNase I, and 3.5 μg of the treated RNA was
used to make cDNA in 20 μl and then diluted two-fold.
Either 2 μl or 4 μl of the diluted cDNA was used in 50 μl
PCRs containing cat primers [186(+) (5' TCT TGCCCGCCT
GAT GAA TGC 3') and 653(-) (5' CCG CCC TGC CAC TCA
TCG CAG 3')] and REDTaq mix (Sigma-Aldrich). PCR
samples were analyzed on 1.5 or 2% agarose gels and
stained with ethidium bromide prior to photography.
Antibodies and Western blotting
Western blot assays were performed essentially as described
previously [5]. Transfected cells were harvested to obtain
whole-cell extracts by addition of one volume of 250 mM
Tris-HCl, pH 6.8, 20% glycerol, 2% sodium dodecyl sulfate
(SDS), 5% 2-mercaptoethanol, and 0.2% bromophenol
blue to cells in one volume of phosphate-buffered saline
(PBS) followed by boiling for 5 minutes. Proteins were
resolved on 10 or 12% polyacrylamide gels containing 1%
SDS and transferred to a nitrocellulose membrane. Mem-
branes were blocked with 5% milk in Tris-buffered saline
Tween 20 (TBST; 20 mM Tris-HCl, pH 7.6, 137 mM NaCl,
and 0.1% Tween 20) for 1 hour. The primary antibody was
diluted in TBST containing 5%milk and incubated with the
membrane for 1 hour followed by three washes in TBST for
5 to 10 minutes each. The horseradish peroxidase-con-
jugated secondary antibody was diluted in TBST containing
1%milk and incubated with the membrane for 45 minutes
prior to three additional 5 to 10 minute washes. All steps
were performed at 25°C with shaking. Western Lightning
enhanced chemiluminescent reagent (Perkin-Elmer) was
used to detect antibody binding. Monoclonal antibodies
specific for actin (Calbiochem) or GFP (Becton Dickinson)
were used at a dilution of 1:10,000 or 1:8000, respectively.
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